Kimberly Manhard, EVP, Drug Development at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 1,504 shares at $4.76 ($7K) on 2022-05-03, disclosed to the SEC on 2022-05-04.
Scheduled sale ($7k) by EVP, Drug Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |
| HRTX | SELL | 2020-12-23 | $200K | — | Filing → |